HJB647

· Novartis Pharmaceuticals

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HJB647, covering 2026-04-15 to 2026-04-15. Get the full timeline:

Most recent: Clinical Trial Update: A Safety and Tolerability Study of HJB647 in Heart Failure Participants With Reduced Ejection Fraction [Phase 1]